Artificial Intelligence
Insights on the Dendritic Cell Cancer Vaccine Immunotherapy Global Market to 2026
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) — The “Global Dendritic Cell Cancer Vaccine Immunotherapy Market, Dosage, Price & Clinical Trials Insight 2026” report has been added to ResearchAndMarkets.com’s offering.
In the past few years, significant breakthroughs in the medical research have led to the opening of novel doors to harness the immune system of the body against the cancer cells. For the very first time in the history of cancer therapeutics, researchers have discovered a cure that incorporates dendritic cells. The introduction of dendritic cell vaccine immunotherapy into the cancer therapeutics has caused several scientific and medical hurdles to overcome as the opportunities linked with dendritic cells treatment for the cancer patients are huge.
Dendritic cell vaccine immunotherapy among all the immunotherapy treatments is considered as the most potent antigen presenting cells for the proliferation of the T-cells. The uniqueness embedded in the treatment have prompted their applications to be involved in the majority of the treatments as well as wider-acceptance across the globe. The potential of immune system in fighting cancer cells got recognized three-four decades before. Since then, technological and innovative advancement in scientific knowledge has led to the development of novel ally for the cancer patients, which has now become the only hope for declining the cancer mortality rate.
The opening of novel research frontiers with the understanding of biological mechanisms underlying the human cancer and immune system are estimated to be creating promising trends and opportunities for the researchers, patients, physicians and the stakeholders. In addition, some of the factors that are leading to the exponential growth of the market in terms of revenue and size are increasing cancer cases, awareness about the advantages of the dendritic cell vaccine immunotherapy, technology advancement and many more. The dendritic cell vaccine immunotherapy market is catalyzed by a completely and exciting novel range of disruptive technologies required for the re-definition of cancer therapeutics market. In the next few years, researchers are estimated to bring a shift in the treatment paradigm where temporary respite of the cancer treatment will not be boosted in the cancer therapeutic challenge. In the new world, dendritic cell vaccine immunotherapy is estimated to be conquering all the challenges that were challenging to conquer before the arrival of the therapy.
The dendritic cell vaccine immunotherapy market for the cancer patients is estimated to be driven by major three developments advancement in the technology, groundbreaking mechanism of action of the dendritic cells against the cancer cells and consumerization of health through increased access to the patient data provided by artificial intelligence. Unlike, chemotherapy or radiation therapy with which disadvantages are more than advantages, dendritic cell vaccine immunotherapy is estimated to be bursting that bubble. The clinical successes achieved through the therapy has led to the downfall of the hype generated by the old and traditional therapies and eventually boosted the products that are already in the market for the consumption.
The future of the market is estimated to reveal the durability of the clinical responses as well as there will be a significant improvement with respect to broad spectrum development of the market. The downward pressure on the pricing of the developed drugs is estimated to change the upsetting of the market, leading to a great emphasis on the market expansion and acceptance at an international level. Along with these, the market is also observing major players emerging for the overall development of the market.
As per the analysis for Dendritic cell vaccine immunotherapy market, it is estimated that the arrival of the therapy into the market has ended the long-waiting scenario of a therapy capable of efficiently manipulating the dendritic cells and targeting it against the cancer cells. The global healthcare industry for cancer was in an urgent need of such promising therapy where patients could have increased five-year survival rate, minimum side-effects, better targeting ability of the manipulated cells and many more. The unprecedented market drivers are providing a deep insight of the market with respect to the overall progression and its aim to re-define the overall success meter in cancer market as the therapy is tending to perform with high rate of performance.
Report Highlights:
- Global Dendritic Cell Cancer Vaccine Clinical Trials: More than 50 Vaccines In Pipeline
- Commercially Available Dendritic Cell Cancer Vaccine: 3 Vaccines
- Dendritic Cell Cancer Vaccine Expected Launches Over Next Decade: More Than 3 Vaccines
- Majority Vaccines In Preclinical Phase: More Than 10 Vaccines
- Global Dendritic Cell Cancer Vaccine Immunotherapy Market Regional Outlook
- Dendritic Cell Vaccines Immunotherapy Clinical Pipeline By Company, Indication & Phase
- Dosage, Efficacy & Price Insight of Provenge, Apceden & CreaVax
Key Topics Covered:
1. Introduction to Dendritic Cell Cancer Vaccine
1.1 Dendritic Cell Cancer Vaccine Historical Development
1.2 Dendritic Cell Vaccines: A New Era for Cancer Immunotherapy
2. Relevance of Dendritic Cells in Immune System & Cancer Therapy
2.1 Dendritic Cell: Integral Part of Human Immune System
2.2 Effects of Cancer on Dendritic Cell Mediated Immunity
3. Dendritic Cell Cancer Vaccines: Mechanism of Action
3.1 Manufacturing of Dendritic Cell Vaccines
3.2 Mechanism of Dendritic Cell Vaccine against Cancer Cells
4. Dendritic Cell Cancer Vaccine In Combination Therapy
4.1 Radiotherapy
4.2 Monoclonal Antibodies
5. Research & Technological Collaborations for Advancing the Dendritic Cell Immunotherapy Market
5.1 UCLA Researchers Re-Defying Research for Dendritic Cell Immunotherapy
5.2 Personalized Dendritic Cell Vaccine Improving the Overall Survival Rate of Glioblastoma Patients
5.3 Cutting-Edge Grant Approval for Dendritic Cell Immunotherapy Market Advancement in UCLA
5.4 Dendritic Cell Cytokines Leading to Increased Clinical Outcome in Case of Different Cancer Types
5.5 Human Telomerase Reverse Transcriptase (hTERT)-Expressing Autologous Dendritic Cells (hTERT-DCs) Efficiency in Case of Acute Myeloid Leukemia
5.6 APAC Biotech Company to Deliver Dendritic Cell Immunotherapy in India
5.7 Nimbus Therapeutics & Celgene to Work Together for Expanding the Applications of Dendritic Cell Therapy
5.8 Specific Dendritic Cell Vaccines ATTAC Study Result for the Treatment of Glioblastoma
5.9 Bristol Myers Squibb & UbiVac Announces Collaboration for Dendritic Cell-Targeted Microvesicle (DPV-001)
5.10 Cancer Research UK & VOLT to Conduct First-in-Human Trial for Dendritic Cell Therapy
5.11 University of California San Diego Research Work for Confirming the Efficacy of Dendritic Cell Cancer Vaccines
5.12 Interleukin-32 Dendritic Cell Therapy Provoking Promising Strategy Treatment
5.13 Elicio Therapeutics & Moffitt to Evaluate the Combinational Outcomes for AMP-CD19 & CD19 CAR-T Cells
5.14 Dendritic Cell Immunotherapy Discovery as Novel Guards for Immune System
5.15 Non-Small Cell Lung Cancer Treatment by Autologous Dendritic Cancer Cell Vaccines
5.16 Dendritic Cell Immunotherapy Preliminary Reports for Solid & Haematological Malignancies
6. Global Dendritic Cell Cancer Vaccine Immunotherapy Current Market Overview
7. Dendritic Cell Cancer Vaccine Immunotherapy Market Regional Outlook
7.1 North America
7.2 India
7.3 South Korea
7.4 Japan
8. Global Dendritic Cell Cancer Vaccine Immunotherapy Clinical Trials Landscape
8.1 By Phase
8.2 By Patient Segment
8.3 By Company
8.4 By Country
8.5 By Cancer
9. Dendritic Cell Cancer Vaccine Immunotherapy – Dosage, Efficacy & Price Insight
9.1 Provenge
9.2 Apceden (Apceden-L, Apceden-O, Apceden-C, Apceden-P)
9.3 CreaVax RCC
10. Comparative Assessment of Provenge v/s other Therapeutics for Prostate Cancer
10.1 Provenge v/s Jevtana
10.1.1 Clinical Efficacy
10.1.2 Treatment Course & Dosage
10.1.3 Therapy Price Analysis
10.2 Provenge v/s Zytiga
10.2.1 Clinical Efficacy
10.2.2 Treatment Course & Dosage
10.2.3 Therapy Price Analysis
11. Global Dendritic Cell Vaccines Immunotherapy Clinical Pipeline By Company, Indication & Phase
11.1 Unknown
11.2 Research
11.3 Preclinical
11.4 Phase-0
11.5 Phase-I
11.6 Phase-I/II
11.7 Phase-II
11.8 Phase-II/III
11.9 Phase-III
12. Marketed Dendritic Cell Vaccines Immunotherapy Clinical Insight
12.1 CreaVax
12.2 Sipuleucel-T (Provenge)
12.3 Dendritic Cell-Activated Cytokine-Induced Killer Cells – Shanghai Jia Fu Medical
13. Promising Future of Dendritic Cell Vaccines in Various Cancer
13.1 Dendritic Cell Vaccine in Stage-III Melanoma
13.2 Dendritic Cell Vaccine in Acute Myeloid Leukemia
13.3 Dendritic Cell Vaccine in Brain Tumor
14. Global Dendritic Cell Cancer Vaccine Market Dynamics
14.1 Favorable Market Parameters
14.2 Market Growth Challenges
15. Global Dendritic Cell Cancer Vaccine Market Future Outlook
15.1 Future Course for Market
15.2 Dendritic Cell Cancer Vaccine Technical Advancements
15.3 Availability of Target Patient Base for Dendritic Cell Cancer Vaccines
16. Competitive Landscape
16.1 3M Company
16.2 Activartis
16.3 Argos Therapeutics
16.4 Batavia Bioservices
16.5 Bellicum Pharmaceuticals
16.6 Creagene
16.7 DanDrit Biotech
16.8 DCPrime
16.9 Dendreon Corporation
16.10 Elios Therapeutics
16.11 ImmunoCellular Therapeutics
16.12 Immunicum
16.13 Kiromic
16.14 Medigene
16.15 Merck
16.16 Northwest Biotherapeutics
16.17 Glaxo Smith Kline
16.18 ImmunoCellular Therapeutics
16.19 SOTIO
16.20 Tella Incorporation
16.21 Theravectys
16.22 Vaxil BioTherapeutics
For more information about this report visit https://www.researchandmarkets.com/r/2u5t12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Artificial Intelligence
New Opportunities for International Businesses: TerraPay Partners with Multipass
DUBAI, UAE, May 7, 2024 /PRNewswire/ — TerraPay, a leading global money movement company, has joined forces with Multipass, a bank challenger in the financial technology sector, to redefine cross-border payment solutions for corporate customers. This strategic collaboration aims to offer unparalleled reliability, efficiency, and cost optimisation to businesses operating in the UK, Europe, and beyond.
Through this partnership, Multipass gains access to TerraPay’s extensive global payments network, expanding its reach to new jurisdictions and local payouts in multiple currencies, ensuring efficient cross-border payment solutions to its clients. Both organizations offer 24/7 customer support and dedicated personal account managers, emphasising the importance of human interaction alongside technological advancement.
Sudhesh Giriyan, President – Cross-Border Payments at TerraPay, expressed enthusiasm about the partnership, stating, “TerraPay is thrilled to collaborate with Multipass to revolutionize cross-border payments for their corporate customers. This partnership underscores our dedication to providing innovative solutions that drive efficiency, reliability, and cost optimisation.”
Rami Chedid, CEO of Multipass for the UAE and the Middle East, commented, “Our partnership with TerraPay represents a significant step forward in our commitment to deliver secure and fast payment solutions to medium-sized entrepreneurs trading internationally. All while prioritizing security and efficiency in speed and costs. As we continue to work on our expansion plans in the UAE, this trusted partnership gives a new level of importance, offering our clients practically a global payment reach.”
He continued to state that Multipass has initiated the application process for a financial services license in UAE to be regulated by The Dubai Financial Services Authority (DFSA), and having received the in-principal approval, the company will launch operations very soon. “This operational expansion will broaden the global payment reach for UAE-based businesses from the very first day, providing them with a competitive edge and opportunities for business growth”, he explains.
About TerraPay:
TerraPay simplifies global money movement – by providing a single connection to the most expansive cross-border payments network regulated in 31 global markets and enabling payments to 144 receive countries, 210+ send countries, 7.5Bn+ bank accounts and 2.1Bn+ mobile wallets. TerraPay is on a mission to connect a borderless financial world, making moving money everywhere instant, reliable, transparent, and fully compliant. TerraPay pushes the boundaries for global businesses – ranging from banks, fintechs and money-transfer operators to travel businesses, creator economy platforms and e-commerce marketplaces – while driving financial inclusion in even the most inaccessible markets. Founded in 2014, TerraPay is headquartered in London, with global offices in Bangalore, Dubai, Miami, Bogota, Dar es Salaam, Kampala, Hague, Dakar, Joburg, Nairobi, Milan, Singapore and is expanding rapidly, having received funding from leading investors, including the IFC (the World Bank), Prime Ventures, Partech Africa, and Visa.
About Multipass:
Multipass a part of Dyninno Group of Companies, is a bank challenger that provides modern financial solutions for businesses with cross-border activity. It offers a multi-currency business account with an instant FX desk and a corporate card that allows international companies to manage their bank transfers in foreign markets in a simple way. Multipass’s customer offering includes local UK, US, and EU (European Union) accounts, as well as a single multi-currency IBAN supporting over 70 currencies and 200 global payment destinations. The company was founded in 2017 and is led by Dmitry Tsymber.
Media Contact:[email protected]
Logo: https://mma.prnewswire.com/media/1222771/TerraPay_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/new-opportunities-for-international-businesses-terrapay-partners-with-multipass-302135467.html
Artificial Intelligence
Rainbow Robotics participates in ICRA 2024 in Yokohama, Japan: Bimanual Mobile Manipulator ‘RB-Y1’ debuts overseas
Participating in the International Conference on Robotics and Automation (ICRA 2024) from the 13th to the 16th AI expert research platform, Bimanual Mobile Manipulator RB-Y1 pre-order beginsDAEJEON, South Korea, May 7, 2024 /PRNewswire/ — Rainbow Robotics (CEO Jungho Lee), a robot platform specialized company, will participate as a bronze sponsor at the IEEE International Conference on Robotics and Automation (ICRA 2024), which will be held at Pacifico Yokohama, Japan on May 13.
During this exhibition, Rainbow Robotics will demonstrate its Bimanual Mobile Manipulator ‘RB-Y1’. RB-Y1 is a humanoid-shaped research platform equipped with two arms with 7 degrees of freedom per arm, a single leg with 6 degrees of freedom, and a wheel-type mobile platform.
In particular, in line with the recent trend of the AI era, Rainbow Robotics plans to provide various APIs and options so that SW developers can easily utilize them for research purposes.
Throughout the exhibition period, various demonstrations will be shown of RB-Y1 with real-time remote operation technology, which links the data arm and simulation system. Additionally, Rainbow Robotics plans to exhibit the small-sized high-precision collaborative robot RB3-730 and the quadruped robot RBQ-10.
ICRA (International Conference on Robotics and Automation) is an event hosted by IEEE (Institute of Electrical and Electronics Engineers) and is the world’s largest robotics conference held annually.
Meanwhile, Rainbow Robotics will begin pre-orders for its Bimanual Mobile Manipulator RB-Y1 from May 8. Customers who purchase during the pre-order period will receive free after-sales service for one year, and products are scheduled to be delivered sequentially starting in October. The research platform is sold for US $ 80,000 and the commercial platform is sold for USD $120,000 (VAT excluded). If you would like to pre-order RB-Y1, please contact us through enquiry page or email us at [email protected].
Photo – https://mma.prnewswire.com/media/2405117/Caption__Rainbow_Robotics_participates_in_ICRA_2024.jpg
View original content:https://www.prnewswire.co.uk/news-releases/rainbow-robotics-participates-in-icra-2024-in-yokohama-japan-bimanual-mobile-manipulator-rb-y1-debuts-overseas-302136589.html
Artificial Intelligence
Solar EV Charging to Bypass the Grid: A US$2.5 Billion Market by 2034, Says IDTechEx
Unreliable and fossil fuel-intense electrical grids
BOSTON, May 6, 2024 /PRNewswire/ — Electrification of cars, buses, and trucks drastically reduces CO2 emissions at the point of use compared to a diesel or petrol alternative. The adoption of EVs across all sectors, with IDTechEx predicting over 180 million electric vehicles to be sold annually by 2044. This will contribute to a drastic reduction in tailpipe emissions. However, the overall emissions are usually highly dependent on the energy mix that goes into grid electricity production. In many economies, this contains significant amounts of fossil fuels such as coal and natural gas. Beyond CO2 emissions, some grids are already at capacity, and the increased load of an electric transport sector risks blackouts and power supply issues. South Africa is an EV market with both of these issues, and several innovations have been made using distributed power generation to tackle these challenges. IDTechEx’s research report, “Off-Grid Charging For Electric Vehicles 2024-2034: Technologies, Benchmarking, Players and Forecasts”, explores the challenges and solutions associated with charging EVs in the context of constrained electricity grids.
The South African utility grid is subject to frequent load-shedding, periods when demand exceeds supply, and utility operators are forced to impose rolling black or brownouts of up to 50% capacity. This is a problem for all forms of domestic and industrial electrical use but becomes an especially pronounced problem for commercial EV operators. Fleet operators often must charge at predesignated times to maximize uptime and complete all planned routes. If the grid fails during a charging spot, the entire schedule may be adversely affected by factors beyond an operator’s control. This is an unusual grid situation; however, it presents a possible worst-case scenario for grid-congested and EV-saturated regions. In 2022, a heatwave in California prompted the state government to ask EV owners not to charge to conserve energy. The growth in electric vehicle sales will only make such problems more widespread.
South Africa also has a very carbon-intensive energy mix, with approximately 70% of power generation being from coal. This directly translates into higher lifecycle CO2 emissions from EVs powered by the electrical grid. Whilst South Africa has a particularly fossil fuel energy mix, the source of electricity plays a critical role in the lifecycle emissions of an electric vehicle.
Disturbed generation gives renewable and grid-independent electricity
One possible solution being trialed in South Africa, amongst other places, is harnessing distributed renewable microgrids to form the backbone of charging networks. By integrating a solar farm, large-scale energy storage (ES), and high-powered charging outlets, Vrendal-based Zero Carbon Charge plans to build an etruck charging network. Not only does this decouple charging from an unreliable grid, it also avoids placing excess electrical demand on utilities, avoids the need for costly grid expansions, and provides free and 100% renewable energy for the trucks to operate on. This is not limited to South Africa; the USA, in particular, has also seen a boom in companies offering grid-free solar-powered charging. In the US, many of the products are smaller scale and transportable, allowing easy setup for EV users who want quick access to EV charging.
Easy setup, no grid connection, but slow charging rates
The main challenge with distributed solar generation for EV charging is the low power output of photovoltaic panels. Most produce around 250 Watts per square meter, which is relatively low. In fact, to charge at 22kW (generally considered Level 2 fast charging), a solar canopy would need to be at least 10 x 10 meters, a considerable footprint, especially in an urban environment. The other challenge is storing energy, as charging will not always be required constantly, so an on-site battery is required to store the generated electricity. Without an integrated on-site battery, charging is impossible when there is no sunlight, such as inclement weather or overnight. On-site battery storage can combat this intermittency.
Larger solar farms with integrated energy storage can become islanded microgrids, and with enough on-site storage and photovoltaic production, potential grid-independent fast charging is possible. This is the approach proposed for the South African etruck charging network. It is important to note that purely solar solutions are likely to be geographically restricted to areas with high photovoltaic potential. Thus, it is no surprise that the leading regions are Western regions of the US and places like South Africa. Beam Global, a supplier of EV canopy chargers, recently announced its first sales in the European market to the United Kingdom Ministry of Defense. However, the chargers will not be deployed in the mainland of the UK; they will be deployed on a military base in Cyprus, one of the sunniest regions on the continent.
Despite technical challenges, the aging and fossil fuel-heavy nature of grids combined with high EV uptake call for new charging solutions, and IDTechEx predicts that solar charging systems will make up a sizeable portion of the overall US$16 billion off-grid charging infrastructure hardware market by 2034. IDTechEx research also indicates several other technologies likely to be adopted for off-grid EV charging. Hydrogen fuel cell charging is likely to emerge as a key solution for use cases requiring much greater power per area, with a particular expected focus on electrified construction sites. More niche technologies include AWE (airborne wind energy), which harnesses high altitude winds for distributed power generation. For an in-depth look at solar EV charging, as well as alternative technology options such as AWE and hydrogen see IDTechEx’s latest research on the topic, “Off-Grid Charging For Electric Vehicles 2024-2034: Technologies, Benchmarking, Players and Forecasts”.
To find out more about this IDTechEx report, including downloadable sample pages, please visit www.IDTechEx.com/OffGridEV.
For the full portfolio of electric vehicle market research from IDTechEx, please see www.IDTechEx.com/Research/EV.
About IDTechEx:
IDTechEx provides trusted independent research on emerging technologies and their markets. Since 1999, we have been helping our clients to understand new technologies, their supply chains, market requirements, opportunities and forecasts. For more information, contact [email protected] or visit www.IDTechEx.com.
Image download:
https://www.dropbox.com/scl/fo/1huh00wjpi6t8tnbrs199/AAjT0rKs4s40ouXmeQ1wefA?rlkey=97jswk3tkb744by19o7cyid47&dl=0
Media Contact:
Lucy RogersSales and Marketing [email protected] +44(0)1223 812300
Social Media Links:
Twitter: www.twitter.com/IDTechEx
LinkedIn: www.linkedin.com/company/IDTechEx
Photo – https://mma.prnewswire.com/media/2406005/Solar_Canopy_Charging.jpgLogo – https://mma.prnewswire.com/media/2338688/4690629/IDTechEx_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/solar-ev-charging-to-bypass-the-grid-a-us2-5-billion-market-by-2034–says-idtechex-302137347.html
-
Artificial Intelligence4 days ago
CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
-
Uncategorized4 days ago
Improving the Developer Journey in Crafting Artificial Intelligence Applications
-
Artificial Intelligence6 days ago
Appdome Unveils World’s First Agentless Mobile EDR & MTD
-
Uncategorized4 days ago
Unveiling the Complex Psychological Implications of Artificial Intelligence
-
Artificial Intelligence4 days ago
5G Enterprise Market Projected to Reach $115.81 billion by 2030 – Exclusive Report by 360iResearch
-
Artificial Intelligence4 days ago
Bitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options
-
Artificial Intelligence4 days ago
Innodisk Introduces iCAP Air: Advancing Air Quality Management through Autonomous Decision-Making
-
Artificial Intelligence4 days ago
Appian Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report